OR13-2 Characterizing the Impact of Burosumab on Bone Health in Children with X-Linked Hypophosphatemia: Results from Year 1 of the Disease Monitoring Program

X-linked hypophosphatemia (XLH) is a rare, heritable disorder wherein excess FGF23 leads to renal phosphate wasting and impaired activation of vitamin D. XLH is characterized by rickets and osteomalacia leading to bone pain, skeletal deformities, and short stature. The XLH Disease Monitoring Program...

Descripción completa

Detalles Bibliográficos
Autores principales: Carpenter, Thomas, Cassinelli, Hamilton, Glorieux, Francis, Hetzer, Joel, Merritt II, J Lawrence, Moreira, Carolina A, Portale, Anthony, Ward, Leanne, Woo, Claudine, Imel, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Bone & Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624613/
http://dx.doi.org/10.1210/jendso/bvac150.395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624613/
http://dx.doi.org/10.1210/jendso/bvac150.395

Ejemplares similares